Last 12 months
Inside the activity.
6 purchase rows · 20 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 3 | 5 |
| Feb 2026 | 0 | 10 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 3 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 09, 2022 Filed May 12, 2022 01:42 UTC |
O'Kane KieranChief Commercial Officer
|
Exercise / conversionCommon Stock | 5,461 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-22-018736 · form4.xml · nonDerivative · entry 1 O'Kane Kieran · CIK 0001828131 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,222 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). F6 · balance_after: Includes 1,157 and 2,604 Shares acquired under the BDSX stock purchase plan on August 31, 2021 and February 28, 2022, respectively. Read SEC document |
| May 09, 2022 Filed May 12, 2022 01:41 UTC |
Pestano Gary AnthonyChief Development Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,676 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-018732 · form4.xml · derivative · entry 4 Pestano Gary Anthony · CIK 0001827711 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,377 Underlying: Common Stock · 3,676 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). F3 · derivative.exercise_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F3 · derivative.expiration_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| May 09, 2022 Filed May 12, 2022 01:41 UTC |
Pestano Gary AnthonyChief Development Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,378 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-018732 · form4.xml · derivative · entry 3 Pestano Gary Anthony · CIK 0001827711 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,674 Underlying: Common Stock · 1,378 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). F2 · derivative.exercise_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F2 · derivative.expiration_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| May 09, 2022 Filed May 12, 2022 01:41 UTC |
Pestano Gary AnthonyChief Development Officer
|
Exercise / conversionCommon Stock | 5,054 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-22-018732 · form4.xml · nonDerivative · entry 1 Pestano Gary Anthony · CIK 0001827711 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,220 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). Read SEC document |
| May 09, 2022 Filed May 12, 2022 01:41 UTC |
Cowie Robin HarperCFO, Sec'y & Treasurer
|
Exercise / conversionRestricted Stock Units · Derivative | 8,418 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-018731 · form4.xml · derivative · entry 4 Cowie Robin Harper · CIK 0001827690 · CFO, Sec'y & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,090 Underlying: Common Stock · 8,418 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). F3 · derivative.exercise_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F3 · derivative.expiration_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| May 09, 2022 Filed May 12, 2022 01:41 UTC |
Cowie Robin HarperCFO, Sec'y & Treasurer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,157 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-018731 · form4.xml · derivative · entry 3 Cowie Robin Harper · CIK 0001827690 · CFO, Sec'y & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,351 Underlying: Common Stock · 3,157 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). F2 · derivative.exercise_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F2 · derivative.expiration_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| May 09, 2022 Filed May 12, 2022 01:41 UTC |
Cowie Robin HarperCFO, Sec'y & Treasurer
|
Exercise / conversionCommon Stock | 11,575 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-22-018731 · form4.xml · nonDerivative · entry 1 Cowie Robin Harper · CIK 0001827690 · CFO, Sec'y & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,833 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). F6 · balance_after: Includes 2,604 Shares acquired under the BDSX stock purchase plan on February 28, 2022. Read SEC document |
| April 07, 2022 Filed Apr 11, 2022 20:35 UTC |
SCHULER JACK WDirector · 10% owner
|
PurchaseCommon Stock | 2,793,296 | $1.79 | $4,999,999.84 |
DisclosureSEC source: 0001567619-22-008352 · doc1.xml · nonDerivative · entry 1 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 11,256,460 F1 · ownership.direct: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. F1 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document |
| April 07, 2022 Filed Apr 11, 2022 20:39 UTC |
PATIENCE JOHNDirector · 10% owner · Chairman
|
PurchaseCommon Stock | 279,329 | $1.79 | $499,998.91 |
DisclosureSEC source: 0001567619-22-008354 · doc1.xml · nonDerivative · entry 1 PATIENCE JOHN · CIK 0001021413 · Director · 10% owner · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 337,926 Read SEC document |
| April 07, 2022 Filed Apr 11, 2022 20:36 UTC |
Strobeck MatthewDirector
|
PurchaseCommon Stock | 558,659 | $1.79 | $999,999.61 |
DisclosureSEC source: 0001567619-22-008353 · doc1.xml · nonDerivative · entry 2 Strobeck Matthew · CIK 0001377832 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Birchview Fund LLC Disclosed balance after: 769,859 F1 · ownership.direct: The reporting person has sole voting and dispositive power with respect to shares held by Birchview Fund, LLC and the Birchview Capital Separately Managed Account in his capacity as Managers of such entities. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. F1 · ownership.nature: The reporting person has sole voting and dispositive power with respect to shares held by Birchview Fund, LLC and the Birchview Capital Separately Managed Account in his capacity as Managers of such entities. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| April 07, 2022 Filed Apr 11, 2022 20:36 UTC |
Strobeck MatthewDirector
|
PurchaseCommon Stock | 558,659 | $1.79 | $999,999.61 |
DisclosureSEC source: 0001567619-22-008353 · doc1.xml · nonDerivative · entry 1 Strobeck Matthew · CIK 0001377832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,545,586 Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 20:16 UTC |
Franchi Jean M.Director
|
Exercise / conversionRestricted Stock Units · Derivative | 20,044 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-012922 · form4.xml · derivative · entry 2 Franchi Jean M. · CIK 0001653053 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,044 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: These restricted stock units vested in full on March 31, 2022 and had no expiration date. F2 · derivative.expiration_date: These restricted stock units vested in full on March 31, 2022 and had no expiration date. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 20:16 UTC |
Franchi Jean M.Director
|
Exercise / conversionCommon Stock | 20,044 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-22-012922 · form4.xml · nonDerivative · entry 1 Franchi Jean M. · CIK 0001653053 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,044 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 20:15 UTC |
Strobeck MatthewDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 20,044 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-012920 · form4.xml · derivative · entry 9 Strobeck Matthew · CIK 0001377832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,044 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: These restricted stock units vested in full on March 31, 2022 and had no expiration date. F2 · derivative.expiration_date: These restricted stock units vested in full on March 31, 2022 and had no expiration date. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 20:15 UTC |
Strobeck MatthewDirector
|
Exercise / conversionCommon Stock | 20,044 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-22-012920 · form4.xml · nonDerivative · entry 1 Strobeck Matthew · CIK 0001377832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 986,927 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 17:51 UTC |
Hutton ScottDirector · President & CEO
|
GrantStock Options (Right to buy) · Derivative | 85,875 | $0.00 Strike: $2.29 | $0.00 |
DisclosureSEC source: 0001567619-22-006913 · doc1.xml · derivative · entry 3 Hutton Scott · CIK 0001697361 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,875 Underlying: Common Stock · 85,875 shares Expires 2032-03-09 Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 17:51 UTC |
Hutton ScottDirector · President & CEO
|
GrantStock Options (Right to buy) · Derivative | 8,423 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001567619-22-006913 · doc1.xml · derivative · entry 2 Hutton Scott · CIK 0001697361 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,846 Underlying: Common Stock · 8,423 shares Expires 2029-03-21 F1 · shares: On March 22, 2019, the Reporting Person was granted an option to purchase 25,269 shares (as-adjusted for the 0.1684664-for-1 reverse stock split effected on October 19, 2020), the vesting of which was subject to the Issuer's satisfaction of certain performance criteria for each of the 2019, 2020 and 2021 fiscal years. The performance criteria was not met for fiscal year 2019, resulting in the cancellation of 8,423 shares underlying the option. F3 · shares: On March 10, 2022, the Compensation Committee confirmed the performance criteria were met for fiscal year 2021, resulting in the vesting of 8,423 shares underlying the option. F1 · derivative.exercise_date: On March 22, 2019, the Reporting Person was granted an option to purchase 25,269 shares (as-adjusted for the 0.1684664-for-1 reverse stock split effected on October 19, 2020), the vesting of which was subject to the Issuer's satisfaction of certain performance criteria for each of the 2019, 2020 and 2021 fiscal years. The performance criteria was not met for fiscal year 2019, resulting in the cancellation of 8,423 shares underlying the option. F3 · derivative.exercise_date: On March 10, 2022, the Compensation Committee confirmed the performance criteria were met for fiscal year 2021, resulting in the vesting of 8,423 shares underlying the option. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 21:54 UTC |
Siurek Ryan HChief Accounting Officer
|
GrantStock Options (Right to buy) · Derivative | 30,887 | $0.00 Strike: $2.29 | $0.00 |
DisclosureSEC source: 0001567619-22-006923 · doc1.xml · derivative · entry 1 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,887 Underlying: Common Stock · 30,887 shares Expires 2032-03-09 Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 21:56 UTC |
Georgantas Robert William IIIChief Scientific Officer
|
GrantStock Options (Right to buy) · Derivative | 22,722 | $0.00 Strike: $2.29 | $0.00 |
DisclosureSEC source: 0001567619-22-006924 · doc1.xml · derivative · entry 1 Georgantas Robert William III · CIK 0001827728 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,722 Underlying: Common Stock · 22,722 shares Expires 2032-03-09 Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 21:51 UTC |
O'Kane KieranChief Commercial Officer
|
GrantStock Options (Right to buy) · Derivative | 6,162 | $0.00 Strike: $2.29 | $0.00 |
DisclosureSEC source: 0001567619-22-006920 · doc1.xml · derivative · entry 3 O'Kane Kieran · CIK 0001828131 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,162 Underlying: Common Stock · 6,162 shares Expires 2032-03-09 Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 21:51 UTC |
O'Kane KieranChief Commercial Officer
|
GrantStock Options (Right to buy) · Derivative | 4,211 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001567619-22-006920 · doc1.xml · derivative · entry 2 O'Kane Kieran · CIK 0001828131 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,423 Underlying: Common Stock · 4,211 shares Expires 2030-04-14 F1 · shares: On April 15, 2020, the Reporting Person was granted an option to purchase 8,423 shares (as-adjusted for the 0.1684664-for-1 reverse stock split effected on October 19, 2020), the vesting of which was subject to the Issuer's satisfaction of certain performance criteria for each of the 2020 and 2021 fiscal years. F3 · shares: On March 10, 2022, the Compensation Committee confirmed the performance criteria were met for fiscal year 2021, resulting in the vesting of 4,211 shares underlying the option. F1 · derivative.exercise_date: On April 15, 2020, the Reporting Person was granted an option to purchase 8,423 shares (as-adjusted for the 0.1684664-for-1 reverse stock split effected on October 19, 2020), the vesting of which was subject to the Issuer's satisfaction of certain performance criteria for each of the 2020 and 2021 fiscal years. F3 · derivative.exercise_date: On March 10, 2022, the Compensation Committee confirmed the performance criteria were met for fiscal year 2021, resulting in the vesting of 4,211 shares underlying the option. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 21:47 UTC |
Pestano Gary AnthonyChief Development Officer
|
GrantStock Options (Right to buy) · Derivative | 5,845 | $0.00 Strike: $2.29 | $0.00 |
DisclosureSEC source: 0001567619-22-006915 · doc1.xml · derivative · entry 3 Pestano Gary Anthony · CIK 0001827711 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,845 Underlying: Common Stock · 5,845 shares Expires 2032-03-09 Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 21:47 UTC |
Pestano Gary AnthonyChief Development Officer
|
GrantStock Options (Right to buy) · Derivative | 5,615 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001567619-22-006915 · doc1.xml · derivative · entry 2 Pestano Gary Anthony · CIK 0001827711 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,230 Underlying: Common Stock · 5,615 shares Expires 2029-03-21 F1 · shares: On March 22, 2019, the Reporting Person was granted an option to purchase 16,845 shares (as-adjusted for the 0.1684664-for-1 reverse stock split effected on October 19, 2020), the vesting of which was subject to the Issuer's satisfaction of certain performance criteria for each of the 2019, 2020 and 2021 fiscal years. The performance criteria was not met for fiscal year 2019, resulting in the cancellation of 5,615 shares underlying the option. F3 · shares: On March 10, 2022, the Compensation Committee confirmed the performance criteria were met for fiscal year 2021, resulting in the vesting of 5,615 shares underlying the option. F1 · derivative.exercise_date: On March 22, 2019, the Reporting Person was granted an option to purchase 16,845 shares (as-adjusted for the 0.1684664-for-1 reverse stock split effected on October 19, 2020), the vesting of which was subject to the Issuer's satisfaction of certain performance criteria for each of the 2019, 2020 and 2021 fiscal years. The performance criteria was not met for fiscal year 2019, resulting in the cancellation of 5,615 shares underlying the option. F3 · derivative.exercise_date: On March 10, 2022, the Compensation Committee confirmed the performance criteria were met for fiscal year 2021, resulting in the vesting of 5,615 shares underlying the option. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 21:39 UTC |
Cowie Robin HarperCFO, Sec'y & Treasurer
|
GrantStock Options (Right to buy) · Derivative | 27,758 | $0.00 Strike: $2.29 | $0.00 |
DisclosureSEC source: 0001567619-22-006911 · doc1.xml · derivative · entry 3 Cowie Robin Harper · CIK 0001827690 · CFO, Sec'y & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,758 Underlying: Common Stock · 27,758 shares Expires 2032-03-09 Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 21:39 UTC |
Cowie Robin HarperCFO, Sec'y & Treasurer
|
GrantStock Options (Right to buy) · Derivative | 5,896 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001567619-22-006911 · doc1.xml · derivative · entry 2 Cowie Robin Harper · CIK 0001827690 · CFO, Sec'y & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,792 Underlying: Common Stock · 5,896 shares Expires 2029-03-21 F1 · shares: On March 22, 2019, the Reporting Person was granted an option to purchase 17,688 shares (as-adjusted for the 0.1684664-for-1 reverse stock split effected on October 19, 2020), the vesting of which was subject to the Issuer's satisfaction of certain performance criteria for each of the 2019, 2020 and 2021 fiscal years. The performance criteria was not met for fiscal year 2019, resulting in the cancellation of 5,896 shares underlying the option. F3 · shares: On March 10, 2022, the Compensation Committee confirmed the performance criteria were met for fiscal year 2021, resulting in the vesting of 5,896 shares underlying the option. F1 · derivative.exercise_date: On March 22, 2019, the Reporting Person was granted an option to purchase 17,688 shares (as-adjusted for the 0.1684664-for-1 reverse stock split effected on October 19, 2020), the vesting of which was subject to the Issuer's satisfaction of certain performance criteria for each of the 2019, 2020 and 2021 fiscal years. The performance criteria was not met for fiscal year 2019, resulting in the cancellation of 5,896 shares underlying the option. F3 · derivative.exercise_date: On March 10, 2022, the Compensation Committee confirmed the performance criteria were met for fiscal year 2021, resulting in the vesting of 5,896 shares underlying the option. Read SEC document |
| March 10, 2022 Filed Mar 18, 2022 20:53 UTC |
Georgantas Robert William IIIChief Scientific Officer
|
GrantStock Options (Right to buy) · Derivative | 2,842 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001567619-22-007219 · doc1.xml · derivative · entry 2 Georgantas Robert William III · CIK 0001827728 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,685 Underlying: Common Stock · 2,842 shares Expires 2030-04-14 F1 · shares: On April 15, 2020, the Reporting Person was granted an option to purchase 5,685 shares (as-adjusted for the 0.1684664-for-1 reverse stock split effected on October 19, 2020), the vesting of which was subject to the Issuer's satisfaction of certain performance criteria for each of the 2020 and 2021 fiscal years. F3 · shares: On March 10, 2022, the Compensation Committee confirmed the performance criteria were met for fiscal year 2021, resulting in the vesting of 2,842 shares underlying the option. F1 · derivative.exercise_date: On April 15, 2020, the Reporting Person was granted an option to purchase 5,685 shares (as-adjusted for the 0.1684664-for-1 reverse stock split effected on October 19, 2020), the vesting of which was subject to the Issuer's satisfaction of certain performance criteria for each of the 2020 and 2021 fiscal years. F3 · derivative.exercise_date: On March 10, 2022, the Compensation Committee confirmed the performance criteria were met for fiscal year 2021, resulting in the vesting of 2,842 shares underlying the option. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 19:08 UTC |
Hutton ScottDirector · President & CEO
|
GrantRestricted Stock Units · Derivative | 195,393 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-004586 · form4.xml · derivative · entry 2 Hutton Scott · CIK 0001697361 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,393 Underlying: Common Stock · 195,393 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F3 · derivative.expiration_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 19:08 UTC |
Hutton ScottDirector · President & CEO
|
GrantRestricted Stock Units · Derivative | 195,392 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-004586 · form4.xml · derivative · entry 1 Hutton Scott · CIK 0001697361 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,392 Underlying: Common Stock · 195,392 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F2 · derivative.expiration_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| February 08, 2022 Filed Feb 11, 2022 00:09 UTC |
Siurek Ryan HChief Accounting Officer
|
GrantRestricted Stock Units · Derivative | 21,341 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-004590 · form4.xml · derivative · entry 2 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,341 Underlying: Common Stock · 21,341 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F3 · derivative.expiration_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| February 08, 2022 Filed Feb 11, 2022 00:09 UTC |
Siurek Ryan HChief Accounting Officer
|
GrantRestricted Stock Units · Derivative | 30,826 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-004590 · form4.xml · derivative · entry 1 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,826 Underlying: Common Stock · 30,826 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F2 · derivative.expiration_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| February 08, 2022 Filed Feb 11, 2022 00:09 UTC |
Cowie Robin HarperCFO, Sec'y & Treasurer
|
GrantRestricted Stock Units · Derivative | 50,508 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-004589 · form4.xml · derivative · entry 2 Cowie Robin Harper · CIK 0001827690 · CFO, Sec'y & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,508 Underlying: Common Stock · 50,508 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F3 · derivative.expiration_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| February 08, 2022 Filed Feb 11, 2022 00:09 UTC |
Cowie Robin HarperCFO, Sec'y & Treasurer
|
GrantRestricted Stock Units · Derivative | 50,508 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-004589 · form4.xml · derivative · entry 1 Cowie Robin Harper · CIK 0001827690 · CFO, Sec'y & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,508 Underlying: Common Stock · 50,508 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F2 · derivative.expiration_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| February 08, 2022 Filed Feb 11, 2022 00:09 UTC |
Pestano Gary AnthonyChief Development Officer
|
GrantRestricted Stock Units · Derivative | 22,053 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-004587 · form4.xml · derivative · entry 2 Pestano Gary Anthony · CIK 0001827711 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,053 Underlying: Common Stock · 22,053 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F3 · derivative.expiration_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| February 08, 2022 Filed Feb 11, 2022 00:09 UTC |
Pestano Gary AnthonyChief Development Officer
|
GrantRestricted Stock Units · Derivative | 22,052 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-004587 · form4.xml · derivative · entry 1 Pestano Gary Anthony · CIK 0001827711 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,052 Underlying: Common Stock · 22,052 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F2 · derivative.expiration_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| February 08, 2022 Filed Feb 11, 2022 00:09 UTC |
O'Kane KieranChief Commercial Officer
|
GrantRestricted Stock Units · Derivative | 23,831 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-004588 · form4.xml · derivative · entry 2 O'Kane Kieran · CIK 0001828131 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,831 Underlying: Common Stock · 23,831 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F3 · derivative.expiration_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| February 08, 2022 Filed Feb 11, 2022 00:09 UTC |
O'Kane KieranChief Commercial Officer
|
GrantRestricted Stock Units · Derivative | 23,831 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-004588 · form4.xml · derivative · entry 1 O'Kane Kieran · CIK 0001828131 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,831 Underlying: Common Stock · 23,831 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F2 · derivative.expiration_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| February 08, 2022 Filed Feb 11, 2022 00:08 UTC |
Georgantas Robert William IIIChief Scientific Officer
|
GrantRestricted Stock Units · Derivative | 22,053 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-004585 · form4.xml · derivative · entry 2 Georgantas Robert William III · CIK 0001827728 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,053 Underlying: Common Stock · 22,053 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F3 · derivative.expiration_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| February 08, 2022 Filed Feb 11, 2022 00:08 UTC |
Georgantas Robert William IIIChief Scientific Officer
|
GrantRestricted Stock Units · Derivative | 31,537 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-004585 · form4.xml · derivative · entry 1 Georgantas Robert William III · CIK 0001827728 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,537 Underlying: Common Stock · 31,537 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F2 · derivative.expiration_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| January 13, 2022 Filed Jan 18, 2022 22:38 UTC |
Cowie Robin HarperCFO, Sec'y & Treasurer
|
Exercise / conversionStock Options (Right to buy) · Derivative | 3,159 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001567619-22-001264 · doc1.xml · derivative · entry 4 Cowie Robin Harper · CIK 0001827690 · CFO, Sec'y & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,210 Underlying: Common Stock · 3,159 shares Expires 2028-04-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option vests in 60 successive, equal monthly installments measured from January 1, 2018. Read SEC document |
| January 13, 2022 Filed Jan 18, 2022 22:38 UTC |
Cowie Robin HarperCFO, Sec'y & Treasurer
|
Exercise / conversionStock Options (Right to buy) · Derivative | 2,520 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001567619-22-001264 · doc1.xml · derivative · entry 3 Cowie Robin Harper · CIK 0001827690 · CFO, Sec'y & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,520 shares Expires 2027-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option vested in 60 successive, equal monthly installments measured from January 1, 2017. Read SEC document |
| January 13, 2022 Filed Jan 18, 2022 22:38 UTC |
Cowie Robin HarperCFO, Sec'y & Treasurer
|
Exercise / conversionCommon Stock | 3,159 | $0.42 | $1,326.78 |
DisclosureSEC source: 0001567619-22-001264 · doc1.xml · nonDerivative · entry 2 Cowie Robin Harper · CIK 0001827690 · CFO, Sec'y & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,654 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 13, 2022 Filed Jan 18, 2022 22:38 UTC |
Cowie Robin HarperCFO, Sec'y & Treasurer
|
Exercise / conversionCommon Stock | 2,520 | $0.42 | $1,058.40 |
DisclosureSEC source: 0001567619-22-001264 · doc1.xml · nonDerivative · entry 1 Cowie Robin Harper · CIK 0001827690 · CFO, Sec'y & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,495 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 30, 2021 Filed Jan 4, 2022 22:04 UTC |
SCHULER JACK WDirector · 10% owner
|
PurchaseCommon Stock | 2,298,850 | $4.35 | $9,999,997.50 |
DisclosureSEC source: 0001567619-22-000278 · doc1.xml · nonDerivative · entry 1 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 8,463,164 F1 · ownership.direct: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. F1 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document |
| December 30, 2021 Filed Jan 4, 2022 21:59 UTC |
PATIENCE JOHNDirector · 10% owner · Chairman
|
PurchaseCommon Stock | 22,988 | $4.35 | $99,997.80 |
DisclosureSEC source: 0001567619-22-000275 · doc1.xml · nonDerivative · entry 2 PATIENCE JOHN · CIK 0001021413 · Director · 10% owner · Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 52,988 Read SEC document |
| December 30, 2021 Filed Jan 4, 2022 21:59 UTC |
PATIENCE JOHNDirector · 10% owner · Chairman
|
PurchaseCommon Stock | 137,931 | $4.35 | $599,999.85 |
DisclosureSEC source: 0001567619-22-000275 · doc1.xml · nonDerivative · entry 1 PATIENCE JOHN · CIK 0001021413 · Director · 10% owner · Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By Patience Enterprises LP Disclosed balance after: 2,078,298 F1 · ownership.direct: The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. F1 · ownership.nature: The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| December 30, 2021 Filed Jan 4, 2022 22:02 UTC |
Strobeck MatthewDirector
|
PurchaseCommon Stock | 9,100 | $4.35 | $39,585.00 |
DisclosureSEC source: 0001567619-22-000277 · doc1.xml · nonDerivative · entry 2 Strobeck Matthew · CIK 0001377832 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Birchview Capital Separately Managed Account Disclosed balance after: 19,933 F1 · ownership.direct: The reporting person has sole voting and dispositive power with respect to shares held by Birchview Fund, LLC and the Birchview Capital Separately Managed Account in his capacity as Managers of such entities. The shares reported herein as held by Birchview Fund, LLC and the shares reported held by Birchview Capital Separately Managed Account were always held for each respective account, but were inadvertently reported as all being held for Birchview Fund, LLC in the Form 4 filed on November 3, 2020. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. F1 · ownership.nature: The reporting person has sole voting and dispositive power with respect to shares held by Birchview Fund, LLC and the Birchview Capital Separately Managed Account in his capacity as Managers of such entities. The shares reported herein as held by Birchview Fund, LLC and the shares reported held by Birchview Capital Separately Managed Account were always held for each respective account, but were inadvertently reported as all being held for Birchview Fund, LLC in the Form 4 filed on November 3, 2020. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| December 30, 2021 Filed Jan 4, 2022 22:02 UTC |
Strobeck MatthewDirector
|
PurchaseCommon Stock | 138,700 | $4.35 | $603,345.00 |
DisclosureSEC source: 0001567619-22-000277 · doc1.xml · nonDerivative · entry 1 Strobeck Matthew · CIK 0001377832 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Birchview Fund LLC Disclosed balance after: 211,200 F1 · ownership.direct: The reporting person has sole voting and dispositive power with respect to shares held by Birchview Fund, LLC and the Birchview Capital Separately Managed Account in his capacity as Managers of such entities. The shares reported herein as held by Birchview Fund, LLC and the shares reported held by Birchview Capital Separately Managed Account were always held for each respective account, but were inadvertently reported as all being held for Birchview Fund, LLC in the Form 4 filed on November 3, 2020. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. F1 · ownership.nature: The reporting person has sole voting and dispositive power with respect to shares held by Birchview Fund, LLC and the Birchview Capital Separately Managed Account in his capacity as Managers of such entities. The shares reported herein as held by Birchview Fund, LLC and the shares reported held by Birchview Capital Separately Managed Account were always held for each respective account, but were inadvertently reported as all being held for Birchview Fund, LLC in the Form 4 filed on November 3, 2020. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| December 30, 2021 Filed Jan 31, 2022 11:02 UTC Amendment |
SCHULER JACK WDirector · 10% owner
|
PurchaseCommon Stock | 2,298,850 | $4.35 | $9,999,997.50 |
DisclosureSEC source: 0000905148-22-000138 · form4.xml · nonDerivative · entry 1 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 8,463,164 F1 · ownership.direct: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. F1 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document |
| December 20, 2021 Filed Dec 22, 2021 16:42 UTC |
Watts Charles MDirector
|
PurchaseCommon Stock | 5,855 | $4.29 | $25,132.00 |
DisclosureSEC source: 0001567619-21-022443 · doc1.xml · nonDerivative · entry 1 Watts Charles M · CIK 0001723751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,855 F1 · price: The price reported in Column 4 is a weighted average price. These shares of Common Stock were purchased in multiple transactions at prices ranging from $4.27 to $4.33, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. Read SEC document |
| December 07, 2021 Filed Dec 8, 2021 21:30 UTC |
Kayyem Jon FaizDirector
|
GrantStock Options (Right to Buy) · Derivative | 27,038 | $0.00 Strike: $5.67 | $0.00 |
DisclosureSEC source: 0001140361-21-040848 · form4.xml · derivative · entry 3 Kayyem Jon Faiz · CIK 0001366268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,038 Underlying: Common Stock · 27,038 shares Expires 2031-12-06 F4 · derivative.exercise_date: This option will vest in full on March 31, 2022, subject to the reporting person's continued service on the Board through the applicable vesting date. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.